siltuximab - CISMeF

Preferred Label : siltuximab;

MeSH note : a chimeric anti-interleukin-6 antibody for treatment of multiple myeloma and renal cell carcinoma; in phase I and phase II clinical trials;

MeSH hyponym : monoclonal antibody CNTO328; monoclonal antibody CNTO 328; monoclonal antibody CNTO-328; cClB8 monoclonal antibody; CNTO 328 monoclonal antibody;

Is substance : O;

UNII : T4H8FMA7IM;

Details

Origin ID

C504234;

UMLS CUI

C1609931;

ATC code(s)
- siltuximab [ATC Code]
CISMeF manual mappings
- Siltuximab (substance) [SNOMED CT concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
Record concept(s)
- CLLB8 [MeSH concept]
- CNTO-328 [MeSH concept]
- Sylvant [MeSH concept]
- siltuximab [MeSH concept]
See also inter- (CISMeF)
- Product containing siltuximab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing siltuximab (medicinal product) [SNOMED CT concept]
- Siltuximab [NCIt concept]
- Siltuximab (substance) [SNOMED CT concept]
- siltuximab [ATC Code]
Validated automatic mappings to BTNT
- siltuximab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients